BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)
Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%
Bio-Techne price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Bio-Techne's price to sales ratio was 9.4× on Nov 11, 2026, against 8.3× a year earlier. Over the last 5 years it ranged from 6.3× to 20.6×, with a median of 10.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.4× | +1.8 |
| 2025 | Dec 31, 2025 | 7.5× | −2.2 |
| 2024 | Dec 31, 2024 | 9.8× | −0.9 |
| 2023 | Dec 29, 2023 | 10.7× | −1.0 |
| 2022 | Dec 30, 2022 | 11.6× | −9.0 |
| 2021 | Dec 31, 2021 | 20.6× | +4.5 |
| 2020 | Dec 31, 2020 | 16.1× | +4.8 |
| 2019 | Dec 31, 2019 | 11.4× | +3.1 |
| 2018 | Dec 31, 2018 | 8.3× | −0.1 |
| 2017 | Dec 29, 2017 | 8.4× | +1.0 |
| 2016 | Dec 30, 2016 | 7.4× | +0.1 |
| 2015 | Dec 31, 2015 | 7.3× | −1.7 |
| 2014 | Dec 31, 2014 | 9.0× | −1.9 |
| 2013 | Dec 31, 2013 | 10.9× | +2.8 |
| 2012 | Dec 31, 2012 | 8.1× | −0.4 |
| 2011 | Dec 30, 2011 | 8.4× | −0.6 |
| 2010 | Dec 31, 2010 | 9.0× | −0.8 |
| 2009 | Dec 31, 2009 | 9.8× | – |
See a number that looks wrong?